Literature DB >> 2442170

Molecular characterization of a mucin-type antigen associated with human pancreatic cancer. The DU-PAN-2 antigen.

M S Lan, A Khorrami, B Kaufman, R S Metzgar.   

Abstract

This work describes the molecular characterization of a human pancreatic cancer-associated antigen defined by a murine monoclonal antibody (DU-PAN-2). DU-PAN-2 antigen was isolated from a pancreatic adenocarcinoma cell line (HPAF) or patient's ascitic fluid, and the antigenic activity was monitored by competitive inhibition radioimmunoassay. Affinity chromatography and CsCl/guanidine HCl density gradient centrifugation were employed to remove other populations of mucin-type glycoproteins and noncovalently associated proteins, respectively. Three electrophoretically distinct components were detected by 1% agarose gel electrophoresis and were resolved by chromatography on Sepharose CL-4B. The major fraction (FII) was subjected to carbohydrate and amino acid analyses. The sum of threonine, serine, proline, glycine, and alanine comprised more than 50% of the amino acid residues. The saccharide units, O-glycosidically linked to the peptide via GalNAc, contained fucose, galactose, GlcNAc, GalNAc, and sialic acid. The total carbohydrate content of FI and FII was 80.8% and 77.4% by weight, respectively. The molecular weight of FII antigen showed two species of molecules of 1.45 X 10(6) and 4.59 X 10(6) by analytical sedimentation equilibrium. DU-PAN-2 antigen was susceptible to neuraminidase, pepsin, Pronase, and papain digestion. These results suggest that both protein components and sialic acid residues may play important roles in the binding of DU-PAN-2 antibody.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442170

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Differential mucin gene expression in human pancreatic and colon cancer cells.

Authors:  S Yonezawa; J C Byrd; R Dahiya; J J Ho; J R Gum; B Griffiths; D M Swallow; Y S Kim
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

2.  Characterization of cell surface antigens expressed in the HMA-1 breast cancer cell line.

Authors:  N Ohuchi; Y Harada; T Masuko; S Matano; S Mori
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

3.  Monoclonal antibody 16D10 to the C-terminal domain of the feto-acinar pancreatic protein binds to membrane of human pancreatic tumoral SOJ-6 cells and inhibits the growth of tumor xenografts.

Authors:  Laurence Panicot-Dubois; Muriel Aubert; Cécile Franceschi; Eric Mas; Françoise Silvy; Christian Crotte; Jean-Paul Bernard; Dominique Lombardo; Marie-Odile Sadoulet
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

4.  Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.

Authors:  D L Barnd; M S Lan; R S Metzgar; O J Finn
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

Review 5.  Composition and production of pancreatic tumor related antigens.

Authors:  H E Appert
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

6.  Expression of the human mucin gene, Muc 1, in normal tissues and metastatic pancreatic tumors.

Authors:  S K Batra; M A Hollingsworth
Journal:  Int J Pancreatol       Date:  1991 Nov-Dec

7.  Xanthogranulomatous cholecystitis expressing high levels of DUPAN-II.

Authors:  Tadashi Uwagawa; Takeyuki Misawa; Takuya Nojiri; Kumiko Kitajima; Makio Kawakami; Katsuhiko Yanaga
Journal:  J Gastroenterol       Date:  2007-07-25       Impact factor: 7.527

8.  α3/4 Fucosyltransferase 3-dependent synthesis of Sialyl Lewis A on CD44 variant containing exon 6 mediates polymorphonuclear leukocyte detachment from intestinal epithelium during transepithelial migration.

Authors:  Jennifer C Brazil; Renpeng Liu; Ronen Sumagin; Keli N Kolegraff; Asma Nusrat; Richard D Cummings; Charles A Parkos; Nancy A Louis
Journal:  J Immunol       Date:  2013-09-25       Impact factor: 5.422

9.  Expression of sialosyl-Tn antigen (monoclonal antibody MLS102 reactive) in normal tissues and malignant tumors of the digestive tract.

Authors:  G Ohshio; H Yoshioka; T Manabe; H Sakahara; H Yamabe; M Imamura; M Inoue; N Tanaka; H Nakada; I Yamashina
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

10.  Rat serum antibodies binding to high-molecular-weight glycoprotein(s) on syngeneic colon carcinomas, demonstrated by competition with rat monoclonal antibody.

Authors:  B Jansson; T Brodin; H O Sjögren
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.